Corient Private Wealth’s Diebold Nixdorf DBD Stock Holding History

Corient Private Wealth’s Portfolio DBD Stock Details DBD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$208K	Buy	+2,446	New	+$197K	﹤0.01%	2789

Other funds holding DBD

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

MCM

Millstreet Capital Management Boston, Massachusetts $368M AUM 57.36% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Corient Private Wealth's DBD Position: Q2 2026 in Review

Corient Private Wealth opened a new position in Diebold Nixdorf (DBD) in Q2 2026: 2,446 shares worth $208K. The stake represents ﹤0.01% of the portfolio and ranks #2789 among its holdings.

216 funds tracked by Wall St. Rank hold DBD as of Q2 2026.

Corient Private Wealth held 2,446 shares of Diebold Nixdorf worth $208K as of Q2 2026.
Diebold Nixdorf was a new Corient Private Wealth position in Q2 2026.
Diebold Nixdorf made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #2789 holding.
216 funds tracked by Wall St. Rank held Diebold Nixdorf as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.